Vitrolife AB (publ)

kr 120.10As of Sun 8 Nov 2026, 12:00 UTC
STO:VITRHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 3.03%
Div yield 0.92%
ROE (46.30%)
Medical Devices
Beta (5Y) 1.66
PE TTM —
TSR TTM (17.63%)
Mkt cap kr 15.94B
ROIC 7.47%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 155
29.00%
(62.09%)
Hold 12|3|2|10|11
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
1.35
1.30
1.32
1.41
16.61%
17.43%
9.12%
5.59%
Revenuekr M
930.1
935.5
918.4
963.1
4.73%
0.49%
(2.13%)
4.93%
Peers (US$1.612B)
Cap (US$)
PE
2.439B
—
1.386B
20.37x
849.4M
30.65x
Capital
TTM
5Y
10Y
Leveragex
1.718
0.082
0.062
EBIT/Intx
2.812
0.180
0.183
Own earn%
58.72
(170.79)
(138.88)
Sh yield%
50.71
37.85
35.65
Owners
Insiders/Inst%
5.34
72.47
Short interest%
4.03
SBC / revenue%
1.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
17–27
$1 testx
0.0
Incr. ROIC%
1